BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22964275)

  • 1. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls.
    Zhuo W; Zhang L; Qiu Z; Zhu B; Chen Z
    Gene; 2012 Nov; 510(1):14-21. PubMed ID: 22964275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects.
    Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
    J Exp Clin Cancer Res; 2012 Jul; 31(1):62. PubMed ID: 22846179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
    Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
    Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk.
    Guo R; Guo X
    Tumour Biol; 2012 Aug; 33(4):1125-32. PubMed ID: 22359202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.
    Han L; Liu Y; Cao W; Yuan X; Li C
    Tumour Biol; 2013 Oct; 34(5):2545-50. PubMed ID: 23918309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis.
    Fan W; Huang Z; Xiao Z; Li S; Ma Q
    J Assist Reprod Genet; 2016 Oct; 33(10):1373-1383. PubMed ID: 27525656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.
    Chen Z; Li Z; Niu X; Ye X; Yu Y; Lu S; Chen Z
    Mutagenesis; 2011 May; 26(3):437-46. PubMed ID: 21402622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis.
    Wu B; Liu K; Huang H; Yuan J; Yuan W; Wang S; Chen T; Zhao H; Yin C
    PLoS One; 2013; 8(12):e85166. PubMed ID: 24391993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population.
    Zheng H; Zhao Y
    Eur J Med Res; 2015 Mar; 20(1):46. PubMed ID: 25886559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.
    Liu C; Jiang Z; Deng QX; Zhao YN
    Asian Pac J Cancer Prev; 2014; 15(11):4689-95. PubMed ID: 24969905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis.
    Li W; Song LQ; Tan J
    Tumour Biol; 2014 Sep; 35(9):9281-90. PubMed ID: 24938875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls.
    Zhuo W; Zhang L; Zhu B; Qiu Z; Chen Z
    PLoS One; 2012; 7(10):e46974. PubMed ID: 23056546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
    Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
    J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk: A systematic review and meta-analysis.
    Ding B; Sun W; Han S; Cai Y; Ren M; Shen Y
    Medicine (Baltimore); 2018 Mar; 97(13):e0210. PubMed ID: 29595663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects.
    Ji YN; Wang Q; Lin XQ; Suo LJ
    Cytokine; 2012 Aug; 59(2):324-34. PubMed ID: 22579698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk.
    Li M; Li YY; Xin XY; Han Y; Wu TT; Wang HB
    Tumour Biol; 2013 Dec; 34(6):3675-80. PubMed ID: 23860774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IKZF1 rs4132601 polymorphism and acute lymphoblastic leukemia susceptibility: a meta-analysis.
    Li S; Ren L; Fan L; Wang G
    Leuk Lymphoma; 2015 Apr; 56(4):978-82. PubMed ID: 25012940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP; Choussein S; Vlahos NF
    Mol Biol Rep; 2012 Nov; 39(11):9921-30. PubMed ID: 22733497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights into etiologies of leukemia: a HuGE review and meta-analysis of CYP1A1 polymorphisms and leukemia risk.
    Han F; Tan Y; Cui W; Dong L; Li W
    Am J Epidemiol; 2013 Aug; 178(4):493-507. PubMed ID: 23707957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CYP1A1 Polymorphisms on Susceptibility to Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
    Wang CD; Chen N; Huang L; Wang JR; Chen ZY; Jiang YM; He YZ; Ji YL
    Biomed Res Int; 2015; 2015():942958. PubMed ID: 26425562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.